We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STXS icon
2876
Stereotaxis
STXS
$141M
$771K ﹤0.01%
151,403
+3,352
+2% +$13.7K
NBN icon
2877
Northeast Bank
NBN
$1.14B
$770K ﹤0.01%
34,217
+517
+2% +$10.9K
SLDB icon
2878
Solid Biosciences
SLDB
$900M
$767K ﹤0.01%
6,745
+1,241
+23% +$78.5K
TREC
2879
DELISTED
Trecora Resources
TREC
$761K ﹤0.01%
108,810
+12,133
+13% +$81.5K
PFBI
2880
DELISTED
Premier Financial Bancorp
PFBI
$756K ﹤0.01%
56,871
+11,170
+24% +$147K
TSBK icon
2881
Timberland Bancorp
TSBK
$351M
$747K ﹤0.01%
30,790
+14,680
+91% +$322K
GTYH
2882
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$747K ﹤0.01%
144,305
+28,507
+25% +$101K
ASC icon
2883
Ardmore Shipping
ASC
$683M
$743K ﹤0.01%
227,021
+56,675
+33% +$181K
BRT
2884
BRT Apartments
BRT
$271M
$743K ﹤0.01%
48,874
+524
+1% +$7.06K
COFS icon
2885
Choiceone Financial
COFS
$510M
$739K ﹤0.01%
23,962
+3,890
+19% +$117K
KRMD icon
2886
KORU Medical Systems
KRMD
$164M
$737K ﹤0.01%
122,310
+38,478
+46% +$215K
BOCH
2887
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$735K ﹤0.01%
74,283
+13,326
+22% +$118K
FSBW icon
2888
FS Bancorp
FSBW
$320M
$732K ﹤0.01%
26,696
+13,794
+107% +$348K
ORRF icon
2889
Orrstown Financial Services
ORRF
$838M
$732K ﹤0.01%
44,240
+5,504
+14% +$85K
XERS icon
2890
Xeris Biopharma Holdings
XERS
$1.45B
$730K ﹤0.01%
148,412
-374
-0.3% -$1.87K
CBMG
2891
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$728K ﹤0.01%
39,571
+272
+0.7% +$4.96K
SBBP
2892
DELISTED
Strongbridge Biopharma plc.
SBBP
$727K ﹤0.01%
299,326
+36,338
+14% +$87.5K
LXRX icon
2893
Lexicon Pharmaceuticals
LXRX
$1.1B
$726K ﹤0.01%
212,299
+11,415
+6% +$21.8K
AVO icon
2894
Mission Produce
AVO
$1.17B
$725K ﹤0.01%
+48,222
New +$651K
DAKT icon
2895
Daktronics
DAKT
$1.04B
$721K ﹤0.01%
154,194
+1,483
+1% +$6.49K
AGRX
2896
DELISTED
Agile Therapeutics
AGRX
$713K ﹤0.01%
124
-36
-23% -$212K
NXTC icon
2897
NextCure
NXTC
$26.7M
$708K ﹤0.01%
5,411
+90
+2% +$11.6K
QUAD icon
2898
Quad
QUAD
$525M
$708K ﹤0.01%
185,314
+22,766
+14% +$69.9K
BFIN
2899
DELISTED
BankFinancial
BFIN
$707K ﹤0.01%
80,504
+1,509
+2% +$12.2K
BELFB
2900
Bel Fuse Inc Class B
BELFB
$4.21B
$706K ﹤0.01%
46,973
+9,227
+24% +$124K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.